Einfluss der Coronapandemie auf die Leberchirurgie und Lebertransplantationen in Deutschland

Zusammenfassung

Hintergrund Die Leberchirurgie ist durch ein hohes perioperatives Risiko und einen großen Ressourcenaufwand geprägt, aber die Operationsindikation ist oftmals alternativlos. Die SARS-CoV-2-Pandemie führte weltweit zu Einschränkungen in der chirurgischen Patientenversorgung und stellte daher auch die Leberchirurgie vor neue Herausforderungen. Welchen Einfluss die Pandemie allerdings auf die Leberchirurgie in Deutschland insgesamt hatte, ist bislang nur unzureichend bekannt.

Methoden Auf Basis der durch das Statistische Bundesamt (Destatis) erfassten Daten zu Prozedurenschlüsseln (OPS-Codes) vollstationärer Patienten in Deutschland aus den Jahren 2010–2020 sowie Daten zu Organtransplantationen der Deutschen Stiftung Organtransplantation (DSO) wurde retrospektiv die Anzahl leberchirurgischer Prozeduren in Deutschland zu Beginn der Pandemie mit den Vorjahresdaten sowie mit Zahlen aus dem Eurotransplant-Raum verglichen.

Ergebnisse Entsprechend der durch das Statistische Bundesamt dokumentierten Prozedurenschlüssel unterlagen Operationen an der Leber sowie Lebertransplantationen in Deutschland in den Jahren 2010 bis 2020 einer jährlichen Schwankung, die auch im Pandemiejahr 2020, im Gegensatz zu anderen europäischen Ländern, unverändert geblieben ist. Die Entwicklung der postmortalen Lebertransplantation sowie der Leberlebendspenden ist in Deutschland, gemäß den Zahlen der DSO, auch im Jahr 2020 stabil geblieben.

Schlussfolgerungen Die Anzahl leberchirurgischer Eingriffe in Deutschland unterlag bis 2020 einer dynamischen Entwicklung, die auch im 1. Pandemiejahr 2020 keine deutliche Veränderung gezeigt hat. Die häufigsten an der Leber durchgeführten Operationen sowie die Lebertransplantation entwickelten sich auch zu Beginn der Pandemie quantitativ weitgehend stabil. Die Veröffentlichung von Daten zu den entsprechenden Prozedurenschlüsseln für das Jahr 2021 bleibt abzuwarten, um die weitere Entwicklung der Leberchirurgie und -transplantation in Deutschland während der SARS-CoV-2-Pandemie beurteilen zu können.

Abstract

Background The SARS-CoV-2 pandemic has led to restrictions in surgical care worldwide and therefore also posed new challenges to liver surgery. The respective procedures often entail high perioperative risks and resource requirements. However, the indication for liver surgery is frequently without alternatives. To date, there is little knowledge about the impact of the pandemic on liver surgery in Germany.

Methods A retrospective data analysis of liver surgery procedures in Germany as well as transplantations was conducted. Evaluations were based on procedure codes recorded between 2010 and 2020 according to diagnosis-related groups (DRG) by the Federal Statistical Office of Germany (Destatis) and data from the German Organ Procurement Organization (Deutsche Stiftung Organtransplantation; DSO).

Results According to DRG procedure codes relating to liver surgery recorded between 2010 and 2020 in Germany, the annual fluctuation for the first year of the pandemic 2020 remained comparable to previous years. Furthermore, the development of post-mortem liver transplantations as well as living liver donations remained stable in Germany in 2020 and 2021.

Conclusions The number of liver surgery procedures in Germany was subject to a dynamic development until 2020, without apparent changes in the first year of the SARS-CoV-2 pandemic. The most frequently performed liver procedures, as well as liver transplantations, remained stable with respect to their annually recorded numbers. Publication of data regarding procedures in liver surgery and transplantation in 2021 need to be awaited and analyzed to evaluate whether the observations presented in this article prove stable any further.

Schlüsselwörter

Leberchirurgie - Leberlebendspende - Leberresektion - Coronavirus - SARS-CoV-2 - COVID-19

Keywords

liver resection - liver surgery - living liver donation - Corona virus - SARS-CoV-2 - COVID-19

Publication History

Received: 08 March 2022

Accepted: 03 May 2022

Article published online:
21 July 2022

• Literatur

• 1 Brake L, Löffler MW, Grundl M. et al. SARS-CoV-2 Infections and Clinical Consequences in a Cohort of Solid Organ Transplant Recipients during the first Wave in Germany – a Single Centre Survey and a Case Report. Zentralbl Chir 2021; 146: 597-604 DOI: 10.1055/a-1552-3983. (PMID: 34587646)
• 2 COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020; 396: 27-38 DOI: 10.1016/S0140-6736(20)31182-X.
• 3 STARSurg Collaborative, COVIDSurg Collaborative. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. Br J Surg 2021; 108: 1448-1464 DOI: 10.1093/bjs/znab336.
• 4 COVIDSurg Collaborative. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg 2020; 107: 1440-1449 DOI: 10.1002/bjs.11746.
• 5 Spinelli A, Pellino G. COVID-19 pandemic: perspectives on an unfolding crisis. Br J Surg 2020; 107: 785-787 DOI: 10.1002/bjs.11627. (PMID: 32191340)
• 6 Caillard S, Anglicheau D, Matignon M. et al. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020; 98: 1549-1558 DOI: 10.1016/j.kint.2020.08.005. (PMID: 32853631)
• 7 Cravedi P, Mothi SS, Azzi Y. et al. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium. Am J Transplant 2020; 20: 3140-3148 DOI: 10.1111/ajt.16185. (PMID: 32649791)
• 8 Dai M, Liu D, Liu M. et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov 2020; 10: 783-791 DOI: 10.1158/2159-8290.CD-20-0422. (PMID: 32345594)
• 9 Fava A, Cucchiari D, Montero N. et al. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study. Am J Transplant 2020; 20: 3030-3041 DOI: 10.1111/ajt.16246. (PMID: 32777153)
• 10 Liang W, Guan W, Chen R. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335-337 DOI: 10.1016/S1470-2045(20)30096-6. (PMID: 32066541)
• 11 Loupy A, Aubert O, Reese PP. et al. Organ procurement and transplantation during the COVID-19 pandemic. Lancet 2020; 395: e95-e96 DOI: 10.1016/S0140-6736(20)31040-0. (PMID: 32407668)
• 12 Qu Z, Oedingen C, Bartling T. et al. Organ procurement and transplantation in Germany during the COVID-19 pandemic. Lancet 2020; 396: 1395 DOI: 10.1016/S0140-6736(20)32213-3. (PMID: 33129390)
• 13 Hanna TP, King WD, Thibodeau S. et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 2020; 371: m4087 DOI: 10.1136/bmj.m4087. (PMID: 33148535)
• 14 COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol 2021; 22: 1507-1517 DOI: 10.1016/S1470-2045(21)00493-9.
• 15 Diers J, Acar L, Baum P. et al. Fewer Operations for Cancer in Germany During the First Wave of COVID-19 in 2020-A Cohort Study and Time-Series Analysis. Dtsch Arztebl Int 2021; 118: 481-482 DOI: 10.3238/arztebl.m2021.0265. (PMID: 34491160)
• 16 Munoz-Martinez S, Sapena V, Forner A. et al. Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Rep 2021; 3: 100260 DOI: 10.1016/j.jhepr.2021.100260. (PMID: 33644725)
• 17 Quante M, Brake L, Tolios A. et al. SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. Transplant Proc 2021; 53: 2421-2434 DOI: 10.1016/j.transproceed.2021.08.019. (PMID: 34551880)
• 18 Rahmel A. Deutsche Transplantationsgesellschaft e. V. (DTG). Organspende und Transplantation zu Beginn des Jahres 2020. Erste Erfahrungen zum Einfluss der SARS-CoV-2-Pandemie in Deutschland. Datenquelle: Deutsche Stiftung Organspende (DSO) 2020 Accessed March 08, 2022 at: https://d-t-g-online.de/images/Presse/2020.04.20__Anlage_Bericht_Organspende_DSO_-_I_Quartal_2020-a.pdf
• 19 Filmann N, Walter D, Schadde E. et al. Mortality after liver surgery in Germany. Br J Surg 2019; 106: 1523-1529 DOI: 10.1002/bjs.11236. (PMID: 31339558)
• 20 Amaddeo G, Brustia R, Allaire M. et al. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area. JHEP Rep 2021; 3: 100199 DOI: 10.1016/j.jhepr.2020.100199. (PMID: 33163949)
• 21 de Vries APJ, Alwayn IPJ, Hoek RAS. et al. Immediate impact of COVID-19 on transplant activity in the Netherlands. Transpl Immunol 2020; 61: 101304 DOI: 10.1016/j.trim.2020.101304. (PMID: 32371150)
• 22 Nevermann NF, Hillebrandt KH, Knitter S. et al. COVID-19 pandemic: implications on the surgical treatment of gastrointestinal and hepatopancreatobiliary tumours in Europe. Br J Surg 2020; 107: e301-e302 DOI: 10.1002/bjs.11751. (PMID: 32521041)
• 23 COVIDSurg Collaborative. Global guidance for surgical care during the COVID-19 pandemic. Br J Surg 2020; 107: 1097-1103 DOI: 10.1002/bjs.11646.
• 24 Bennett S, Soreide K, Gholami S. et al. Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic. Curr Oncol 2020; 27: e501-e511 DOI: 10.3747/co.27.6785. (PMID: 33173390)
• 25 Brajcich BC, Benson AB, Gantt G. et al. Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative. J Surg Oncol 2022; 125: 560-563 DOI: 10.1002/jso.26758. (PMID: 34820843)
• 26 Hillebrandt K, Nevermann N, Globke B. et al. Impact of the COVID-19 pandemic on hepato-pancreato-biliary surgery and organ transplantation. Chirurg 2021; 92: 918-923 DOI: 10.1007/s00104-021-01463-0. (PMID: 34297148)
• 27 Yuan Q, Haque O, Coe TM. et al. The Heterogenous Effect of COVID-19 on Liver Transplantation Activity and Waitlist Mortality in the United States. Front Surg 2021; 8: 669129 DOI: 10.3389/fsurg.2021.669129. (PMID: 34095209)